Skip to content

Comparison of safety and effectiveness in between topical Adapalene plus clindamycin and topical Adapalene plus benzoyl peroxide for treatment of inflammatory Acne vulgaris

Efficacy and Safety of Topical Adapalene(0.1%W/W) & CLINDAMYCIN(1%W/W) versus Topical Adapalene(0.1%W/W) & Benzoyl peroxide(2.5%W/W) in Inflammatory Acne Vulgaris: A Comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062423
Enrollment
34
Registered
2024-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Adapalene with Benzoyl peroxide: Fixed dose combination of topical Adapalene(0.1% w/w) and Benzoyl peroxide(2.5%w/w) Control Intervention1: Adapalene with Clindamycin: Fixed dose combin

Sponsors

DR SOUMIK BISWAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of 18 years and below 30 years of age of either sex

Exclusion criteria

Exclusion criteria: Patients of 30 years and above of age of either sex

Design outcomes

Primary

MeasureTime frame
changes in Inflammatory lesion count, Investigator global assessment score, Cardiff acne disability index from baseline will be assessed to determine the outcome at 4th, 8th and 12th weekTimepoint: changes in Inflammatory lesion count, Investigator global assessment score, Cardiff acne disability index from baseline will be assessed to determine the outcome at 4th, 8th and 12th week

Secondary

MeasureTime frame
Severity of inflammatory acne vulgaris & medication adherence score will be assessed at baseline to determine the outcome at 4th, 8th & 12th weekTimepoint: Severity of inflammatory acne vulgaris & medication adherence score will be assessed at baseline to determine the outcome at 4th, 8th & 12th week

Countries

India

Contacts

Public ContactDr SOUMIK BISWAS

Nilratan Sircar Medical College

drarijitghosh@gmail.com9874727137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026